A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancer

A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancer

Abstract Background We conducted a phase I/Ib, open-label, single-arm trial to assess the safety, tolerability and optimal scheduling regimen of OTSGC-A24 cancer vaccine in patients with advanced gastric cancer. Methods Patients with advanced gastric cancer with HLA-A*24:02 haplotype were included i...

Full description

Bibliographic Details
Main Authors: Raghav Sundar, Sun Young Rha, Hiroki Yamaue, Masahiro Katsuda, Koji Kono, Hyo Song Kim, Chan Kim, Kousaku Mimura, Ley-Fang Kua, Wei Peng Yong
Format: Article
Language:English
Published: BMC 2018-03-01
Series:BMC Cancer
Subjects:
OTSGC-A24
Cancer vaccine
Phase I
Gastric cancer
Online Access:http://link.springer.com/article/10.1186/s12885-018-4234-8

Internet

http://link.springer.com/article/10.1186/s12885-018-4234-8

Similar Items